Keyphrases
Tumor
73%
E-cadherin
40%
Immunohistochemistry
28%
Gastric Cancer
27%
Carcinoma
22%
Tumor Cells
22%
Gastric Carcinoma
18%
Esophageal Adenocarcinoma
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
In Situ Hybridization
16%
Prognostic Factors
15%
Loss of Heterozygosity
14%
Plasminogen Activator inhibitor-1 (PAI-1)
14%
Breast Cancer
14%
Neoadjuvant Chemotherapy
13%
Formalin-fixed Paraffin-embedded Tissue
13%
Pathologist
12%
Formalin-fixed
12%
Overall Survival
12%
Lymph Node Metastasis
12%
Immunoreactivity
11%
Gene Expression
11%
Urokinase-type Plasminogen Activator
11%
Chemotherapy
11%
Microsatellite Instability-high (MSI-H)
11%
Paraffin-embedded Tissue
11%
Esophageal Squamous Cell Carcinoma
10%
Overexpression
10%
Epidermal Growth Factor Receptor
10%
Primary Tumor
10%
Fluorescence in Situ Hybridization
10%
Adenocarcinoma
9%
Metastasis
9%
Cytokeratin
9%
5-fluorouracil (5-FU)
9%
Polymerase Chain Reaction
9%
Quantitative PCR
9%
E-cadherin mutations
9%
Prognostic Value
9%
Paraffin Embedding
8%
Barrett's Adenocarcinoma
8%
Neoadjuvant
8%
Tumor Tissue
8%
Upper Gastrointestinal Tract
8%
Lymph Node
8%
MRNA Expression
8%
Carcinoid
8%
E-cadherin Gene
8%
Molecular Analysis
8%
Cell Adhesion Molecules
8%
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
33%
Carcinoma
25%
Abdominal Cancer
24%
Immunohistochemistry
23%
Tumor Cell
22%
Adenocarcinoma
18%
Prognostic Factor
17%
Messenger RNA
17%
Lymph Node
16%
Uvomorulin
15%
Stomach Carcinoma
14%
Neoadjuvant Chemotherapy
14%
Lung
14%
Diseases
13%
Metastatic Carcinoma
13%
Urokinase
12%
Plasminogen Activator Inhibitor-1
12%
Esophageal Adenocarcinoma
12%
Protein P53
12%
Overall Survival
11%
Malignant Neoplasm
11%
Carcinoid
11%
Gene Expression
11%
Pathologist
11%
Morphology
11%
Neuroendocrine Tumor
10%
Cancer
10%
Esophagus
9%
Polymerase Chain Reaction
9%
Lymph Node Metastasis
9%
Breast Carcinoma
8%
Protein Expression
7%
Cytokeratin
7%
Immunoreactivity
7%
In Situ Hybridization
7%
Adenoma
7%
Epidermal Growth Factor Receptor
7%
Primary Tumor
7%
Gene Mutation
6%
Colorectal Carcinoma
6%
Biopsy Technique
6%
Biological Marker
6%
Multivariate Analysis
6%
Molecular Pathology
6%
Non-Hodgkin Lymphoma
6%
Oncogene
6%
Carcinogenesis
5%
Barrett Esophagus
5%
Epstein Barr Virus
5%
Biochemistry, Genetics and Molecular Biology
Cadherin
41%
Messenger RNA
16%
Loss of Heterozygosity
15%
Gene Mutation
14%
Gene Expression
13%
Fluorescence in Situ Hybridization
12%
Exon
12%
Plasminogen Activator Inhibitor-1
12%
Epidermal Growth Factor Receptor
11%
Microsatellite Instability
10%
Urokinase
10%
Comparative Genomic Hybridization
10%
Protein Expression
9%
Carcinogenesis
9%
Oncogene
8%
Tumor Suppressor Gene
8%
Cisplatin
8%
Overall Survival
8%
P53
8%
Germline Mutation
7%
Protein Microarray
7%
Genetics
7%
Proteomics
7%
Receptor Tyrosine Kinase
7%
Tissue Section
6%
Polymerase Chain Reaction
6%
Laser Microdissection
6%
Upper Digestive Tract
6%
Allele
6%
RNA
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Cell Adhesion Proteins
6%
Esophagus
6%
Imaging Mass Spectrometry
6%
Cytogenetics
5%
Gene Amplification
5%
Fluorouracil
5%
Colon
5%
Gene Expression Profiling
5%
Microsatellite
5%
Tumor Progression
5%
Cancer Cell
5%
